Showing results (311-320 of 1,023) with videos related to
Sort By:
Pageof 103
Annals of Human Genetics|February 1, 1981
Electrophoretic analysis of glycoprotein enzymes in the sialidoses and mucolipidosesD M Swallow, J S O'Brien, A T Hoogeveen, et al.Clinical Neurosurgery|January 1, 1975
Monitoring of patients with head injuriesG T Tindall, J M Patton, J J Dunion, et al.Rheumatology (Oxford, England)|August 26, 1999
Identification of thiopurine methyltransferase (TPMT) polymorphisms cannot predict myelosuppression in systemic lupus erythematosus patients taking azathioprineM A Naughton, E Battaglia, S O'Brien, et al.Health Trends|December 9, 1994
Deliberate self harm: the hidden populationS Cullum, S O'Brien, A Burgess, et al.Cancer|October 24, 2000
Therapeutic choices in younger patients with chronic myelogenous leukemiaH M Kantarjian, F J Giles, S O'Brien, et al.The Canadian Journal of Urology|December 21, 2017
Blueprint unknown: a case for multidisciplinary management of advanced penile mycosis fungoidesJonathan S O'Brien, Todd Manning, Marlon Perera, et al.Journal of Neuropathology and Experimental Neurology|October 9, 2001
TX14(A), a prosaposin-derived peptide, reverses established nerve disorders in streptozotocin-diabetic rats and prevents them in galactose-fed ratsA P Mizisin, R C Steinhardt, J S O'Brien, et al.Hematologic Pathology|January 1, 1988
Tumor necrosis factor and human hematopoiesis: II. Inhibition and mode of action on normal and chronic myelogenous leukemia-derived granulocyte-macrophage progenitor cellsM Beran, S O'Brien, B Andersson, et al.Leukemia|June 25, 1998
GM-CSF can improve the cytogenetic response obtained with interferon-alpha therapy in patients with chronic myelogenous leukemiaJ Cortes, H Kantarjian, S O'Brien, et al.Letters in Applied Microbiology|February 18, 2009
Prevalence of Cronobacter species (Enterobacter sakazakii) in follow-on infant formulae and infant drinksS O'Brien, B Healy, C Negredo, et al.Pageof 103